Your browser doesn't support javascript.
loading
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.
Seyrek, Neslisah; Hollemans, Eva; Osanto, Susanne; Pelger, Rob C M; van der Poel, Henk G; Bekers, Elise; Bangma, Chris H; Rietbergen, John; Roobol, Monique J; Schoots, Ivo G; van Leenders, Geert J L H.
Afiliação
  • Seyrek N; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hollemans E; Department of Radiology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Osanto S; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Pelger RCM; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • van der Poel HG; Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Bekers E; Department of Urology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bangma CH; Department of Pathology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rietbergen J; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Roobol MJ; Department of Urology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
  • Schoots IG; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Leenders GJLH; Department of Radiology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Histopathology ; 80(3): 558-565, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34706119
AIMS: Gleason pattern 4 (GP4) percentage, invasive cribriform and/or intraductal carcinoma (IC/IDC) and the presence of tertiary Gleason pattern 5 (TP5) in radical prostatectomy (RP) specimens all aid in the risk stratification of Grade Group (GG) 2 prostate cancer patients. However, it is unclear to what extent these pathological features are mutually related and what are their individual values if they are investigated simultaneously. The aims of this study were: (i) to determine the mutual relationships of the GP4 percentage, IC/IDC and TP5 in GG2 RP specimens; and (ii) to assess their prognostic value for biochemical recurrence-free survival (BCRFS). METHODS AND RESULTS: Of 1064 RP specimens, 472 (44.4%) showed GG2 prostate cancer. Patients with ≥25% GP4 more frequently had IC/IDC (67.0% versus 43.9%; P < 0.001) and TP5 (20.6% versus 5.8%; P < 0.001) than those with <25% GP4. In unadjusted analysis, an increased GP4 percentage [hazard ratio (HR) 1.3; 95% confidence interval (CI) 1.0-1.6; P = 0.04] and IC/IDC (log rank P < 0.001) were associated with shorter BCRFS, whereas TP5 (P = 0.12) and a dichotomised (<25%, ≥25%) GP4 percentage (P = 0.10) were not. In multivariable analysis, IC/IDC was an independent prognostic factor (HR 1.9; 95% CI 1.2-2.9; P = 0.005) for BCRFS, whereas a continuous or dichotomised GP4 percentage and TP5 were not independent prognostic factors. CONCLUSION: In conclusion, a higher GP4 percentage in RP specimens was associated with more frequent IC/IDC and TP5. IC/IDC was an independent predictor for BCRFS, whereas the GP4 percentage and TP5 were not. These findings underscore the importance of routinely including the presence of IC/IDC in RP pathology reports.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias da Próstata / Adenocarcinoma / Gradação de Tumores Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Histopathology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias da Próstata / Adenocarcinoma / Gradação de Tumores Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Histopathology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda